Longduoduo Co Ltd (LDDD) stock: key figures, P/E, revenue and dividend

Health Care · China · ISIN US54303E2090

Price
0.51 USD
Market cap
15.31 m USD
P/E (2026)
–
P/S (2026)
8.40
Dividend yield
0.00 %
Net margin
-31.75 %
Return on equity (ROE)
-82.23 %
Return on assets (ROA)
-28.04 %

Longduoduo Co Ltd financials

Fiscal year20252026
Revenue4.26 m USD1.82 m USD
Gross profit4.17 m USD1.81 m USD
Operating income552,679.00 USD-633,181.00 USD
EBIT714,528.00 USD-575,816.00 USD
Net income460,435.00 USD-578,631.00 USD
Diluted EPS – continuing operations0.02 USD-0.02 USD

Full history since 2020, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Longduoduo Co Ltd

Longduoduo Company Limited, together its subsidiaries, provides preventive healthcare solutions in the People's Republic of China. The company offers range of preventive healthcare services, including disease screening, healthcare treatments, healthcare products, and other services for the prevention of myocardial infarction, cerebral infarction, hemiplegia, and cardiovascular and cerebrovascular diseases through third-party healthcare service providers, product suppliers, and sales agents. It also provides meridian-regulating and consciousness restoring iatrotechnics; double blood purification; immunological ozonated autohemotherapy; platelet-rich plasma; relaxation therapy; vegetative nerve regulation; and microwave therapy. The company was founded in 2020 and is headquartered in Hohhot, China.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 13.11.2026. Details in the risk notice.